Jiangsu Aoyang Health Industry Co.ltd. (SHE:002172)

SHE:002172 Revenue

Jiangsu Aoyang Health Industry Co.ltd. had revenue of 426.02M CNY in the quarter ending September 30, 2026, a decrease of -6.91%. This brings the company's total for the last twelve months to 1.70B, down -9.30% year-over-year. In the year 2025, Jiangsu Aoyang Health Industry Co.ltd. had annual revenue of 1.81B, down -10.10%. That makes Jiangsu Aoyang Health Industry Co.ltd. the 15,694th largest company in the world by revenue and 2,816th in China.

• Revenue (ttm): 1.70B
• Revenue Growth: -9.30%
• P/S Ratio: 1.92
• Revenue / Employee: 842.45K
• Employees: 2,012
• Market Cap: 3.25B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Division 1.13B 53.8%
• Medical Division 974.02M 46.2%

Fiscal year ended Dec 31, 2025 See the full SHE:002172 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.81B	-202.94M	-10.10%
Dec 31, 2024	2.01B	-163.99M	-7.54%
Dec 31, 2023	2.17B	152.46M	7.54%
Jan 1, 2023	2.02B	591.94M	41.41%
Jan 1, 2022	1.43B	-455.73M	-24.18%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error